Fingolimod reduces the brain volume loss in relapsing-remitting multiple sclerosis irrespective of baseline inflammatory activity: results from FREEDOMS phase III study: O280


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles